454
Effect of Revalor-XH Compared with Revalor-IH Followed By Revalor-200 on Feedlot Performance and Carcass Characteristics of Heifers Fed to Three Different Endpoints

Wednesday, March 14, 2018: 8:30 AM
216 (CenturyLink Convention Center)
Grant I. Crawford, Merck Animal Health, DeSoto, KS
John P. Hutcheson, Merck Animal Health, DeSoto, KS
Ben P. Holland, Cactus Feeders, Amarillo, TX
Alyssa B. Word, Cactus Feeders, Amarillo, TX
Wade T. Nichols, Merck Animal Health, DeSoto, KS
Marshall N. Streeter, Merck Animal Health, DeSoto, KS
Mark E Corrigan, Merck Animal Health, DeSoto, KS
Brandon L Nuttelman, Merck Animal Health, DeSoto, KS
Crossbred heifers (n = 3,780; initial BW = 309 ± 55 kg) were utilized in a serial harvest experiment to compare the effects of two growth-promoting implant programs on feedlot performance and carcass characteristics. A traditional heifer re-implant program consisting of a Revalor-IH (80 mg trenbolone acetate [TBA] and 8 mg estradiol) at experiment initiation followed by a Revalor-200 (200 mg TBA, 20 mg estradiol) on day 90 was compared with a single Revalor-XH at experiment initiation. Revalor-XH contains 200 mg TBA and 20 mg estradiol in a proprietary coated extended-release formulation, with 4 uncoated pellets consisting of 80 mg TBA and 8 mg estradiol, and 6 coated pellets consisting of 120 mg TBA and 12 mg estradiol. Heifers were harvested after 172, 193, and 214 days-on-feed (DOF) resulting in a 2 x 3 factorial arrangement of treatments (2 implant treatments, 3 serial harvest groups). Heifers were assigned randomly into 54 pens with 70 heifers/pen, resulting in 9 replications/treatment. Revalor-XH heifers were not removed from their pens during the experiment. There were no implant treatment x serial harvest interactions (P > 0.05) for carcass-adjusted performance or carcass characteristics. Increasing DOF resulted in a linear increase (P < 0.03) in carcass-adjusted final BW, HCW, dressing percentage, and percent USDA Prime and Choice carcasses, and a linear decrease (P ≤ 0.01) in ADG, DMI, G:F, and percent USDA Select carcasses. Percentage of heifers reaching USDA yield grade 4 and 5 increased (P ≤ 0.01) with increasing DOF. Based on changes in live BW and HCW as DOF progressed, the proportion of live BW gain captured as HCW (carcass transfer) was 80%. Carcass-adjusted final BW (P = 0.06) and HCW (P = 0.09) tended to be greater for Revalor-IH/200 heifers than for Revalor-XH heifers. Dry matter intake tended (P = 0.06) to be greater, and ADG (P = 0.03) and G:F (P < 0.01) were lower for Revalor-XH heifers than for Revalor-IH/200 heifers. Dressing percentage (P = 0.21) and USDA quality grade distribution (P > 0.16) were not affected by implant treatment. Revalor-XH heifers produced more (P < 0.01) USDA Yield Grade 4 and 5 carcasses than Revalor-IH/200 heifers, with no differences (P > 0.15) in USDA Yield Grade 1, 2, or 3 carcasses. Compared to a Revalor-IH/200 implant strategy, heifers implanted with Revalor-XH had 1.2% lower ADG and 2.0% lower G:F while producing similar USDA quality grades. These data indicate that utilizing Revalor-XH is a viable alternative to re-implanting in feedlot heifers.